Global Influenza Therapeutics Market Research Report 2024(Status and Outlook)

Global Influenza Therapeutics Market Research Report 2024(Status and Outlook)



Report Overview:

Influenza, commonly known as the flu, is an infectious disease caused by an influenza virus.

The Global Influenza Therapeutics Market Size was estimated at USD 7201.62 million in 2023 and is projected to reach USD 9541.09 million by 2029, exhibiting a CAGR of 4.80% during the forecast period.

This report provides a deep insight into the global Influenza Therapeutics market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Influenza Therapeutics Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Influenza Therapeutics market in any manner.

Global Influenza Therapeutics Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Abbott Laboratories

Astrazeneca PLC

Biocryst Pharmaceuticals, Inc.

Chiron Corporation

CSL Limited

Daiichi Sankyo Co., Ltd.

Glaxosmithkline PLC

Mitsubishi Tanabe Pharma Corporation

Nanotherapeutics Inc.

Protein Sciences Corporation

Roche Holding AG

Sanofi SA

Shionogi & Co., Ltd.

Sinovac Biotech Ltd.

Market Segmentation (by Type)

Vaccines

Drugs

Market Segmentation (by Application)

Hospitals

Clinic

Others

Geographic Segmentation
  • North America (USA, Canada, Mexico)
  • Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
  • South America (Brazil, Argentina, Columbia, Rest of South America)
  • The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
  • Industry drivers, restraints, and opportunities covered in the study
  • Neutral perspective on the market performance
  • Recent industry trends and developments
  • Competitive landscape & strategies of key players
  • Potential & niche segments and regions exhibiting promising growth covered
  • Historical, current, and projected market size, in terms of value
  • In-depth analysis of the Influenza Therapeutics Market
  • Overview of the regional outlook of the Influenza Therapeutics Market:
Key Reasons to Buy this Report:
  • Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
  • This enables you to anticipate market changes to remain ahead of your competitors
  • You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
  • The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
  • Provision of market value (USD Billion) data for each segment and sub-segment
  • Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
  • Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
  • Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
  • Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
  • The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
  • Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
  • Provides insight into the market through Value Chain
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • 6-month post-sales analyst support
Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Note: this report may need to undergo a final check or review and this could take about 48 hours.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Influenza Therapeutics Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.


1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Influenza Therapeutics
1.2 Key Market Segments
1.2.1 Influenza Therapeutics Segment by Type
1.2.2 Influenza Therapeutics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Influenza Therapeutics Market Overview
2.1 Global Market Overview
2.1.1 Global Influenza Therapeutics Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Influenza Therapeutics Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Influenza Therapeutics Market Competitive Landscape
3.1 Global Influenza Therapeutics Sales by Manufacturers (2019-2024)
3.2 Global Influenza Therapeutics Revenue Market Share by Manufacturers (2019-2024)
3.3 Influenza Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Influenza Therapeutics Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Influenza Therapeutics Sales Sites, Area Served, Product Type
3.6 Influenza Therapeutics Market Competitive Situation and Trends
3.6.1 Influenza Therapeutics Market Concentration Rate
3.6.2 Global 5 and 10 Largest Influenza Therapeutics Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Influenza Therapeutics Industry Chain Analysis
4.1 Influenza Therapeutics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Influenza Therapeutics Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Influenza Therapeutics Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Influenza Therapeutics Sales Market Share by Type (2019-2024)
6.3 Global Influenza Therapeutics Market Size Market Share by Type (2019-2024)
6.4 Global Influenza Therapeutics Price by Type (2019-2024)
7 Influenza Therapeutics Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Influenza Therapeutics Market Sales by Application (2019-2024)
7.3 Global Influenza Therapeutics Market Size (M USD) by Application (2019-2024)
7.4 Global Influenza Therapeutics Sales Growth Rate by Application (2019-2024)
8 Influenza Therapeutics Market Segmentation by Region
8.1 Global Influenza Therapeutics Sales by Region
8.1.1 Global Influenza Therapeutics Sales by Region
8.1.2 Global Influenza Therapeutics Sales Market Share by Region
8.2 North America
8.2.1 North America Influenza Therapeutics Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Influenza Therapeutics Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Influenza Therapeutics Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Influenza Therapeutics Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Influenza Therapeutics Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Abbott Laboratories
9.1.1 Abbott Laboratories Influenza Therapeutics Basic Information
9.1.2 Abbott Laboratories Influenza Therapeutics Product Overview
9.1.3 Abbott Laboratories Influenza Therapeutics Product Market Performance
9.1.4 Abbott Laboratories Business Overview
9.1.5 Abbott Laboratories Influenza Therapeutics SWOT Analysis
9.1.6 Abbott Laboratories Recent Developments
9.2 Astrazeneca PLC
9.2.1 Astrazeneca PLC Influenza Therapeutics Basic Information
9.2.2 Astrazeneca PLC Influenza Therapeutics Product Overview
9.2.3 Astrazeneca PLC Influenza Therapeutics Product Market Performance
9.2.4 Astrazeneca PLC Business Overview
9.2.5 Astrazeneca PLC Influenza Therapeutics SWOT Analysis
9.2.6 Astrazeneca PLC Recent Developments
9.3 Biocryst Pharmaceuticals, Inc.
9.3.1 Biocryst Pharmaceuticals, Inc. Influenza Therapeutics Basic Information
9.3.2 Biocryst Pharmaceuticals, Inc. Influenza Therapeutics Product Overview
9.3.3 Biocryst Pharmaceuticals, Inc. Influenza Therapeutics Product Market Performance
9.3.4 Biocryst Pharmaceuticals, Inc. Influenza Therapeutics SWOT Analysis
9.3.5 Biocryst Pharmaceuticals, Inc. Business Overview
9.3.6 Biocryst Pharmaceuticals, Inc. Recent Developments
9.4 Chiron Corporation
9.4.1 Chiron Corporation Influenza Therapeutics Basic Information
9.4.2 Chiron Corporation Influenza Therapeutics Product Overview
9.4.3 Chiron Corporation Influenza Therapeutics Product Market Performance
9.4.4 Chiron Corporation Business Overview
9.4.5 Chiron Corporation Recent Developments
9.5 CSL Limited
9.5.1 CSL Limited Influenza Therapeutics Basic Information
9.5.2 CSL Limited Influenza Therapeutics Product Overview
9.5.3 CSL Limited Influenza Therapeutics Product Market Performance
9.5.4 CSL Limited Business Overview
9.5.5 CSL Limited Recent Developments
9.6 Daiichi Sankyo Co., Ltd.
9.6.1 Daiichi Sankyo Co., Ltd. Influenza Therapeutics Basic Information
9.6.2 Daiichi Sankyo Co., Ltd. Influenza Therapeutics Product Overview
9.6.3 Daiichi Sankyo Co., Ltd. Influenza Therapeutics Product Market Performance
9.6.4 Daiichi Sankyo Co., Ltd. Business Overview
9.6.5 Daiichi Sankyo Co., Ltd. Recent Developments
9.7 Glaxosmithkline PLC
9.7.1 Glaxosmithkline PLC Influenza Therapeutics Basic Information
9.7.2 Glaxosmithkline PLC Influenza Therapeutics Product Overview
9.7.3 Glaxosmithkline PLC Influenza Therapeutics Product Market Performance
9.7.4 Glaxosmithkline PLC Business Overview
9.7.5 Glaxosmithkline PLC Recent Developments
9.8 Mitsubishi Tanabe Pharma Corporation
9.8.1 Mitsubishi Tanabe Pharma Corporation Influenza Therapeutics Basic Information
9.8.2 Mitsubishi Tanabe Pharma Corporation Influenza Therapeutics Product Overview
9.8.3 Mitsubishi Tanabe Pharma Corporation Influenza Therapeutics Product Market Performance
9.8.4 Mitsubishi Tanabe Pharma Corporation Business Overview
9.8.5 Mitsubishi Tanabe Pharma Corporation Recent Developments
9.9 Nanotherapeutics Inc.
9.9.1 Nanotherapeutics Inc. Influenza Therapeutics Basic Information
9.9.2 Nanotherapeutics Inc. Influenza Therapeutics Product Overview
9.9.3 Nanotherapeutics Inc. Influenza Therapeutics Product Market Performance
9.9.4 Nanotherapeutics Inc. Business Overview
9.9.5 Nanotherapeutics Inc. Recent Developments
9.10 Protein Sciences Corporation
9.10.1 Protein Sciences Corporation Influenza Therapeutics Basic Information
9.10.2 Protein Sciences Corporation Influenza Therapeutics Product Overview
9.10.3 Protein Sciences Corporation Influenza Therapeutics Product Market Performance
9.10.4 Protein Sciences Corporation Business Overview
9.10.5 Protein Sciences Corporation Recent Developments
9.11 Roche Holding AG
9.11.1 Roche Holding AG Influenza Therapeutics Basic Information
9.11.2 Roche Holding AG Influenza Therapeutics Product Overview
9.11.3 Roche Holding AG Influenza Therapeutics Product Market Performance
9.11.4 Roche Holding AG Business Overview
9.11.5 Roche Holding AG Recent Developments
9.12 Sanofi SA
9.12.1 Sanofi SA Influenza Therapeutics Basic Information
9.12.2 Sanofi SA Influenza Therapeutics Product Overview
9.12.3 Sanofi SA Influenza Therapeutics Product Market Performance
9.12.4 Sanofi SA Business Overview
9.12.5 Sanofi SA Recent Developments
9.13 Shionogi and Co., Ltd.
9.13.1 Shionogi and Co., Ltd. Influenza Therapeutics Basic Information
9.13.2 Shionogi and Co., Ltd. Influenza Therapeutics Product Overview
9.13.3 Shionogi and Co., Ltd. Influenza Therapeutics Product Market Performance
9.13.4 Shionogi and Co., Ltd. Business Overview
9.13.5 Shionogi and Co., Ltd. Recent Developments
9.14 Sinovac Biotech Ltd.
9.14.1 Sinovac Biotech Ltd. Influenza Therapeutics Basic Information
9.14.2 Sinovac Biotech Ltd. Influenza Therapeutics Product Overview
9.14.3 Sinovac Biotech Ltd. Influenza Therapeutics Product Market Performance
9.14.4 Sinovac Biotech Ltd. Business Overview
9.14.5 Sinovac Biotech Ltd. Recent Developments
10 Influenza Therapeutics Market Forecast by Region
10.1 Global Influenza Therapeutics Market Size Forecast
10.2 Global Influenza Therapeutics Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Influenza Therapeutics Market Size Forecast by Country
10.2.3 Asia Pacific Influenza Therapeutics Market Size Forecast by Region
10.2.4 South America Influenza Therapeutics Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Influenza Therapeutics by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Influenza Therapeutics Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Influenza Therapeutics by Type (2025-2030)
11.1.2 Global Influenza Therapeutics Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Influenza Therapeutics by Type (2025-2030)
11.2 Global Influenza Therapeutics Market Forecast by Application (2025-2030)
11.2.1 Global Influenza Therapeutics Sales (K Units) Forecast by Application
11.2.2 Global Influenza Therapeutics Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings